title: Therapy of heart failure.
authors.affiliation: Division of Renal Diseases and Hypertension, University of Colorado School of Medicine, Denver 80262, USA. Tevfik.Ecder@UCHSC.edu
authors.forename: T
authors.initials: T
authors.lastname: Ecder
authors.forename: D
authors.initials: D
authors.lastname: Korular
authors.forename: A K
authors.initials: AK
authors.lastname: Gurevich
authors.forename: H D
authors.initials: HD
authors.lastname: Weinberger
authors.forename: R W
authors.initials: RW
authors.lastname: Schrier
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D004232:Diuretics / Q000627:therapeutic use; D006333:Heart Failure / Q000209:etiology / Q000628:therapy*; D006801:Humans; D044140:Receptor, Angiotensin, Type 1; D014665:Vasodilator Agents / Q000627:therapeutic use
chemical_list: D000319:Adrenergic beta-Antagonists; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics; D044140:Receptor, Angiotensin, Type 1; D014665:Vasodilator Agents